Connect with us
Information

Australia
North America
World

Investing News NetworkYour trusted source for investing success

North America
Australia
World
My INN

Private Placements

Reports & Guides
- Market Outlook Reports
- Investing Guides
Button

Precious Metals
Battery Metals
Base Metals
Energy
Critical Minerals

rx:cc

POPULAR ARTICLES

FeraMAX is Canada's Top-Ranked Iron Supplement for 11 Consecutive Years

pharmaceutical investing

FeraMAX is Canada's Top-Ranked Iron Supplement for 11 Consecutive Years

BioSyent Announces Grant of Restricted Share Units

pharmaceutical investing

BioSyent Announces Grant of Restricted Share Units

BioSyent Releases Financial Results for Fourth Quarter and Full Year 2025

pharmaceutical investing

BioSyent Releases Financial Results for Fourth Quarter and Full Year 2025

LATEST ARTICLES

BioSyent Schedules Fourth Quarter and Full Year 2025 Earnings Release for March 19, 2026

pharmaceutical investing

BioSyent Schedules Fourth Quarter and Full Year 2025 Earnings Release for March 19, 2026

BioSyent Announces Closing of the Acquisition of Oral Science Inc.

pharmaceutical investing

BioSyent Announces Closing of the Acquisition of Oral Science Inc.

BioSyent to Acquire Oral Science Inc.

pharmaceutical investing

BioSyent to Acquire Oral Science Inc.

BioSyent Declares First Quarter 2026 Dividend

pharmaceutical investing

BioSyent Declares First Quarter 2026 Dividend

BioSyent Announces Renewal of Normal Course Issuer Bid

pharmaceutical investing

BioSyent Announces Renewal of Normal Course Issuer Bid

BioSyent Releases Financial Results for Q3 and YTD 2025

pharmaceutical investing

BioSyent Releases Financial Results for Q3 and YTD 2025

BioSyent Declares Fourth Quarter 2025 Dividend

pharmaceutical investing

BioSyent Declares Fourth Quarter 2025 Dividend

BioSyent Schedules Q3 and YTD 2025 Earnings Release for November 20, 2025

pharmaceutical investing

BioSyent Schedules Q3 and YTD 2025 Earnings Release for November 20, 2025

BioSyent Releases Financial Results for Q2 and H1 2025

pharmaceutical investing

BioSyent Releases Financial Results for Q2 and H1 2025

BioSyent Declares Third Quarter 2025 Dividend

pharmaceutical investing

BioSyent Declares Third Quarter 2025 Dividend

BioSyent Schedules Q2 and H1 2025 Earnings Release for August 21, 2025

pharmaceutical investing

BioSyent Schedules Q2 and H1 2025 Earnings Release for August 21, 2025

Latest News

Brixton Metals Announces Closing of Non-Brokered Private Placement for Gross Proceeds of $4 Million

Domestic Metals to Host Live Investor Webinar

Quebec Innovative Materials Corp. Announces U.S. Affiliate Orvian Receives Minnesota DNR Registration for Exploratory Boring

Prismo Metals Completes Phase 1 Drill Campaign at Silver King

Napie Grows to 1.2Moz Au and Aurum Reaches 4.2Moz Au

Outlook Reports world

Precious Metals
- Gold
- Silver
Battery Metals
Energy
- Uranium
- Oil and Gas

Base Metals
Critical Metals
- Rare Earths
Industrial Metals
Agriculture

- Cleantech
- Emerging Tech

- Biotech
- Cannabis

- Psychedelics
- Pharmaceuticals

Featured Stocks

Cauldron Energy

CXU:AU

U92 Energy

U92 Energy (UTWO:CC)

UTWO:CC

Raptor Metals

Raptor Metals (RAP:AU)

RAP:AU

Centurion Minerals

Centurion Minerals (CTN:CC)

CTN:CC

Fathom Nickel

Fathom Nickel (FNI:CC)

FNI:CC

MetalSource Mining

MSM:CC

More featured stocks

Browse Companies

Precious Metals
Battery Metals
Energy

Base Metals
Critical Metals

MARKETS

COMMODITIES

CURRENCIES